Management of Mucositis Secondary to Cancer Therapy
Publication Date: June 30, 2020
Last Updated: March 14, 2022
Guidelines
Basic Oral Care
The panel suggests that implementation of multiagent combination oral care protocols is beneficial for the prevention of OM during CT. (Level III)
318512
Table 2. Recommended Intraoral Photobiomodulation Therapy Protocols for the Prevention of Oral Mucositis
Having trouble viewing table?
| Cancer Treatment Modality | Wavelength, nm | Power Density (Irradiance), mW/cm2 | Time per Spot, s | Energy Density (Fluence), J/cm2 | Spot Size, cm2 | No. of Sites | Duration |
|---|---|---|---|---|---|---|---|
| HSCT | 632.8 | 31.25 | 40 | 1.0 | 0.8 | 18 | From the d after cessation of conditioning for 5 d |
| 650 | 1000b | 2 | 2.0 | 0.04 | 54-70 | From the first d of conditioning to d + 2 post-HSCT (for 7-13 d) | |
| RT | 632.8 | 24 | 125 | 3.0 | 1.00 | 12 | Entire RT course |
| RT-CT | 660 | 417b | 10 | 4.2 | 0.24 | 72 | Entire RT course |
| 660 | 625b | 10 | 6.2 | 0.04 | 69 | Entire RT course |
Overview
Title
Management of Mucositis Secondary to Cancer Therapy
Authoring Organization
Multinational Association of Supportive Care in Cancer